These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 788897

  • 21. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.
    Alvarez V, Lodillinsky C, Umerez S, Sandes E, Eiján AM.
    Int J Mol Med; 2005 Oct; 16(4):565-71. PubMed ID: 16142388
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
    Tomazic VJ, Farha M, Loftus A, Elias EG.
    J Immunol; 1988 Jun 01; 140(11):4056-61. PubMed ID: 3372997
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of bacille Calmette-Guerin immunotherapy on feline sarcoma virus-induced neoplasms in the cat.
    Bachman D, Cockerell GL, de Noronha F, Rapp HJ.
    Am J Vet Res; 1982 Mar 01; 43(3):475-80. PubMed ID: 6280529
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Experimental and clinical trials with BCG immunotherapy.
    Sparks FC, Silverstein MJ, Hunt JS, O'Connell TX, Lee YT, Pilch YH, Haskell CM, Morton DL.
    Johns Hopkins Med J Suppl; 1974 Mar 01; 3():103-20. PubMed ID: 4609024
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
    Kreider JW, Bartlett GL, Boyer CM, Purnell DM.
    Cancer Res; 1979 Mar 01; 39(3):987-92. PubMed ID: 427785
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Preoperative intralesional Bacillus Calmette-Guérin for mammary adenocarcinoma in rats.
    Lee YT.
    Cancer Res; 1977 Oct 01; 37(10):3679-83. PubMed ID: 908015
    [Abstract] [Full Text] [Related]

  • 34. Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-Guérin and tumor cells.
    Zbar B, Canti G, Rapp HJ, Ashley MP, Sukumar S, Bast RC.
    Cancer Res; 1980 Apr 01; 40(4):1036-42. PubMed ID: 7357533
    [No Abstract] [Full Text] [Related]

  • 35. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors.
    Talmadge JE, Fidler IJ.
    J Natl Cancer Inst; 1982 Oct 01; 69(4):975-80. PubMed ID: 6750200
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Effect of BCG (Bacillus Calmette Guérin) sensitization on the generation of tumor specific killer T cells].
    Takeuchi M, Kimoto M, Suzuki I, Nomoto K.
    Gan To Kagaku Ryoho; 1983 Sep 01; 10(9):1980-6. PubMed ID: 6604499
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.